Rytol Bioscience is a leading Canadian biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases. Specializing in brain oncology and Central Nervous System disorders. Rytol Bioscience developing a first in class mRNA treatment for Glioma as well as treatments for Acute Myeloid Leukemia, Epilepsy and Renal cancer. The company continues to build upon its existing pipeline and broaden its clinical opportunities.
Company Details
- Employees
- 4
- Address
- Greater Vancouver, Bc, Ca
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.rytolscience.com
- Keywords
- Environmental Services.
- HQ
- Greater Vancouver, BC
Rytol Bioscience Questions
Rytol Bioscience's website is https://www.rytolscience.com
Rytol Bioscience's LinkedIn profile is https://ca.linkedin.com/company/rytol-bioscience
Rytol Bioscience has
4 employees.
View email and phone details for 4
employees at Rytol Bioscience.
Rytol Bioscience's industry is
Pharmaceutical Manufacturing
Rytol Bioscience's top competitors are
Abalone Bio,
Gamma Proteins,
Abvion,
Mabsolve,
Pegasus Biotech Inc.,
Caro Analytical Services,
Afrobodies,
Iiba® Glo,
Protein Stable,
Immunochem.
Rytol Bioscience's categories are Pharmaceutical Manufacturing
